metastasis articles & resources on Made-in-China.com

Dormant Prostate Cancer Cells Found in Bone Tissue Can Be Reawakened

Feb 25, 2014

Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of the body. ...

Tags: Prostate Cancer Cells, reawakened, preventing the spread of disease

Researchers Identified Critical Complex Mechanisms Involved in The Metastasis of Deadly

Jan 20, 2014

A team of researchers from the Cleveland Clinic and Case Western Reserve School of Medicine have identified critical complex mechanisms involved in the metastasis of deadly "triple negative" breast cancers (TNBC). These tumors are extremely ...

Tags: Life-Saving Treatments, ight Tumor Metastasis, Life-Saving

Breast Cancer Stem Cells Exist in Two Different States

Jan 15, 2014

Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes cancer a deadly ...

Tags: Health, Medicine, cancer

A Research Group at Biocenter Oulu in Finland Has Identified a Mechanism

Jan 14, 2014

A research group at Biocenter Oulu in Finland has identified a mechanism related to a transcription factor that binds much more strongly onto a particular SNP variant, thereby initiating a genetic programme which enhances prostate cancer ...

Tags: prostate cancer, proliferation, metastasis, SNP variations, mechanism

BCS Has Been Shown to Reduce The Risk of Breast Cancer (BC) Recurrence

Dec 27, 2013

Radiotherapy (RT) after breast conserving surgery (BCS) has been shown to reduce the risk of breast cancer (BC) recurrence. However, although younger women tend to have more aggressive tumors and have higher risks of recurrence than older ...

Tags: Radiotherapy, breast conserving surgery, breast cancer

Patient Enrollment in Cosy Clinical Trial Has Been Completed by Surefire Medical

Dec 13, 2013

US-based Surefire Medical has completed enrollment in the Coiling vs. Surefire infusion system in Y90 (COSY) clinical trial. This randomized prospective study investigates the feasibility and benefits of performing Selective Internal ...

Tags: Surefire Medical, infusion system, enrollment, COSY, SIRT

Navidea Biopharmaceuticals Will Collaborate with The UAB on a Clinical Study

Nov 29, 2013

Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...

Tags: Health, Medicine

Agalimmune Has Been Created to Develop Innovative Immunotherapeutics

Nov 29, 2013

Agalimmune, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours. The new company has been founded by an investment group comprising Loxbridge ...

Tags: solid tumours, cancer treatment

The Patent Application Covers Synta's Proprietary HDC Technology

Nov 4, 2013

Synta Pharmaceuticals has announced the publication of the company's first patent application covering its proprietary Hsp90-inhibitor drug conjugate (HDC) platform, which leverages the company's expertise in chaperone biology and medicinal ...

Tags: Health, Medicine

MetaStat Announced Women's Breast Cancer Has Confirmed

Oct 10, 2013

US-based MetaStat has announced that a study of 481 women with breast cancer has confirmed that the MetaSite Score (a count of the number of TMEM structures) was found to be associated with a statistically significant increase in the risk ...

Tags: MetaStat, Breast Cancer

Castle Biosciences Announced Data Was Strong Predictor for Classifying

Aug 6, 2013

Castle Biosciences has announced that data from studies of its DecisionDx-Melanoma test confirm previous studies, indicating that the gene expression profile test is a strong predictor for classifying which Stage I or II non-metastatic ...

Tags: Non-Metastatic Melanoma Recurrence Risk

GIS Identified Potential Targets for Therapeutic Drugs Against Aggressive Breast Cancer.

Jul 30, 2013

Researchers at A*STAR’s Genome Institute of Singapore (GIS) have identified potential targets for therapeutic drugs against aggressive breast cancer. Working in collaboration with local and international institutions, GIS scientists ...

Tags: therapeutic drugs, Medicine

Alethia Biotherapeutics Has Gained Us Patent for Methods of Treating Carcinomas

May 21, 2013

Alethia Biotherapeutics has gained US patent for methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoting epithelial-to-mesenchymal transition (EMT). The company along with ...

Tags: Alethia, US Patent, Cancer Treatment Methods

Exelixis Has Announced The Availability of Cometriq (Cabozantinib)

Jan 29, 2013

Exelixis has announced the availability of Cometriq (cabozantinib), indicated for medullary thyroid cancer (MTC), in the US. Diplomat Specialty Pharmacy is distributing the product across the US. Cometriq that is developed to inhibit ...

Tags: Exelixis, Cometriq, tyrosine kinases

NanoSight Reports on The Breakthrough Cancer Metastasis Research

Jan 17, 2013

NanoSight, leading manufacturers of unique nanoparticle characterisation technology, reports on the breakthrough cancer metastasis research of Dr Hector Peinado Selgas and Dr David Lyden's research team from Weill Cornell Medical College. ...

Tags: NanoSight, cancer metastasis, characterisation technology

metastasis

Related Products